SEC Form 4 · accession 0001209191-17-051631
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Natalie Sacks
Officer — Chief Medical Officer
Period of report
Sep 1, 2017
Accepted (ET)
Sep 6, 2017 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2017 | S | 4,885 | $11.7085 | D | 45,115 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.